Literature DB >> 31187224

Inhibitory activity of chitosan nanoparticles against Cryptosporidium parvum oocysts.

Shahira A Ahmed1, Heba S El-Mahallawy2, Panagiotis Karanis3.   

Abstract

Cryptosporidium is a ubiquitous harsh protozoan parasite that resists many disinfectants. It remains viable and infective for a long time in water and food causing global outbreaks. Chitosan (the deacetylated chitin molecule) was used in its nanosuspension form to evaluate its effect against Cryptosporidium parvum. The experiments were performed in vitro in serial concentrations and confirmed in mice in vivo infectivity assay. Chitosan nanoparticles (Cs NPs) were toxic to Cryptosporidium oocysts. The effect appeared to decrease the number of Cryptosporidium oocysts and altered their content. The destruction rate of oocysts was dependent on the dose of chitosan and the time of exposure (P < 0.05). Higher doses of Cs NPs over a prolonged period exhibited a significantly higher destruction rate. Using staining and light microscopy, remarkable destructive changes were observed in the oocysts' morphology. The minimal lethal dose for > 90% of oocysts was 3000 μg/ml, no mice infections in vivo were observed. The results in this study elucidate Cs NPs as an effective anti-cryptosporidial agent.

Entities:  

Keywords:  Activity; Bioassay; Chitosan; Cryptosporidium; In vitro; Nanoparticles

Mesh:

Substances:

Year:  2019        PMID: 31187224     DOI: 10.1007/s00436-019-06364-0

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  58 in total

1.  Assessment of drugs against Cryptosporidium parvum using a simple in vitro screening method.

Authors:  A Armson; B P Meloni; J A Reynoldson; R C Thompson
Journal:  FEMS Microbiol Lett       Date:  1999-09-15       Impact factor: 2.742

2.  Microencapsulated chitosan nanoparticles for lung protein delivery.

Authors:  Ana Grenha; Begoña Seijo; Carmen Remuñán-López
Journal:  Eur J Pharm Sci       Date:  2005 Jul-Aug       Impact factor: 4.384

Review 3.  Waterborne transmission of protozoan parasites: a worldwide review of outbreaks and lessons learnt.

Authors:  Panagiotis Karanis; Christina Kourenti; Huw Smith
Journal:  J Water Health       Date:  2007-03       Impact factor: 1.744

4.  Enhancement of nasal absorption of insulin using chitosan nanoparticles.

Authors:  R Fernández-Urrusuno; P Calvo; C Remuñán-López; J L Vila-Jato; M J Alonso
Journal:  Pharm Res       Date:  1999-10       Impact factor: 4.200

5.  Evaluation and applicability of a purification method coupled with nested PCR for the detection of Toxoplasma oocysts in water.

Authors:  C Kourenti; P Karanis
Journal:  Lett Appl Microbiol       Date:  2006-11       Impact factor: 2.858

6.  Capture and retention of Cryptosporidium parvum oocysts by Pseudomonas aeruginosa biofilms.

Authors:  Kristin E Searcy; Aaron I Packman; Edward R Atwill; Thomas Harter
Journal:  Appl Environ Microbiol       Date:  2006-09       Impact factor: 4.792

7.  Inter-laboratory comparison of the CD-1 neonatal mouse logistic dose-response model for Cryptosporidium parvum oocysts.

Authors:  D G Korich; M M Marshall; H V Smith; J O'Grady; Z Bukhari; C R Fricker; J P Rosen; J L Clancy
Journal:  J Eukaryot Microbiol       Date:  2000 May-Jun       Impact factor: 3.346

8.  Preparation and antibacterial activity of chitosan nanoparticles.

Authors:  Lifeng Qi; Zirong Xu; Xia Jiang; Caihong Hu; Xiangfei Zou
Journal:  Carbohydr Res       Date:  2004-11-15       Impact factor: 2.104

9.  A new approach for targeting to Cryptosporidium parvum using mucoadhesive nanosuspensions: research and applications.

Authors:  O Kayser
Journal:  Int J Pharm       Date:  2001-02-19       Impact factor: 5.875

10.  Comparison of fluorescence, antigen and PCR assays to detect Cryptosporidium parvum in fecal specimens.

Authors:  Ralf Bialek; Nicole Binder; Klaus Dietz; Anja Joachim; Jürgen Knobloch; Ulrike E Zelck
Journal:  Diagn Microbiol Infect Dis       Date:  2002-08       Impact factor: 2.803

View more
  5 in total

1.  Remarkable histopathological improvement of experimental toxoplasmosis after receiving spiramycin-chitosan nanoparticles formulation.

Authors:  Amal Farahat Allam; Nancy Abd-Elkader Hagras; Hoda Fahmy Farag; Mervat Mostafa Osman; Thanaa Ibrahim Shalaby; Amani Hussein Kazem; Amel Youssef Shehab; Nermine Mogahed Fawzy Hussein Mogahed
Journal:  J Parasit Dis       Date:  2021-08-10

2.  Assessment of chitosan nanoparticles in improving the efficacy of nitazoxanide on cryptosporidiosis in immunosuppressed and immunocompetent murine models.

Authors:  Howayda Said Fouad Moawad; Mohamed Hegab Abd El-Hady Hegab; Maha Saber Reda Badawey; Shaimaa Elsayed Ashoush; Shereen Mahmoud Ibrahim; Amira Abd El-Lateef Saleh Ali
Journal:  J Parasit Dis       Date:  2021-01-06

Review 3.  An Overview of Mucosa-Associated Protozoa: Challenges in Chemotherapy and Future Perspectives.

Authors:  Helena Lucia Carneiro Santos; Karina M Rebello
Journal:  Front Cell Infect Microbiol       Date:  2022-04-25       Impact factor: 6.073

4.  Chitosan Protects Immunosuppressed Mice Against Cryptosporidium parvum Infection Through TLR4/STAT1 Signaling Pathways and Gut Microbiota Modulation.

Authors:  Sajid Ur Rahman; Haiyan Gong; Rongsheng Mi; Yan Huang; Xiangan Han; Zhaoguo Chen
Journal:  Front Immunol       Date:  2022-01-14       Impact factor: 7.561

Review 5.  Nanoparticles for antiparasitic drug delivery.

Authors:  Yuzhu Sun; Dongmei Chen; Yuanhu Pan; Wei Qu; Haihong Hao; Xu Wang; Zhenli Liu; Shuyu Xie
Journal:  Drug Deliv       Date:  2019-12       Impact factor: 6.419

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.